Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Alliacense Letter to Amazon

Letter dated Oct 15, 2007 - Our preliminary research indicates Amazon.com has already accrued approximately $130M of royalty exposure for past damages under the MMP Portfolio.

$130,000,000 \ 405,948,183 (shares) = .32 per share

That’s one.

Sorry, I couldn’t help doing it…

Share
New Message
Please login to post a reply